Patents by Inventor John Flanagan

John Flanagan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260170677
    Abstract: Methods include acquiring a series of images or spectra of a volume of a model sample, reconstructing a 3D image of the volume of the model sample using the series of images, constructing a 3D model of the volume of the model sample by forming a segmentation of the reconstructed 3D image and fitting one or more primitive geometrical shapes to the segmentation, acquiring test sample images or spectra, and measuring test sample critical dimensions using the constructed 3D model to guide analysis of test spectra or images. Additional methods and related systems are disclosed, optical critical dimension (OCD) methods and systems.
    Type: Application
    Filed: February 5, 2026
    Publication date: June 18, 2026
    Applicant: FEI Company
    Inventors: John Flanagan, Mary Wu, Erik Franken, Daniel Lichau
  • Patent number: 12601747
    Abstract: The invention provides a method of diagnosing Non-Alcoholic Steatohepatitis (NASH) and/or the hepatic fibrosis status of a subject, especially a subject afflicted with Non-alcoholic fatty liver disease (NAFLD) or NASH, based on the level of only three or more particular biomarkers. The invention further provides a kit suitable for performing said method and the use of said method and methods of treating patients diagnosed in accordance with the disclosed methods.
    Type: Grant
    Filed: November 6, 2023
    Date of Patent: April 14, 2026
    Assignee: BIO-RAD LABORATORIES, INC.
    Inventors: Isabelle Batxelli-Molina, Florian Salipante, Roger P. Walker, John Flanagan, Jeannette Fareh-Michiel
  • Publication number: 20260094340
    Abstract: A computer-implemented method for generating synthetic data describing a sample can comprise processing, by a system operatively coupled to a processor, sample information describing a set of original features of a sample, resulting in processed model input information, and generating, by an analytical model, synthetic image data, usable to generate a synthetic image, and describing at least a portion of the set of original features and based on the processed model input information. The computer-implemented method further can comprise generating, by the system, the synthetic image of a pseudo-sample, based on the synthetic image data, having at least one pseudo-feature that is different from and based on the set of original features.
    Type: Application
    Filed: February 21, 2025
    Publication date: April 2, 2026
    Inventors: Jamie Dee Gravell, Tomáš Onderlicka, Matej Dolník, Zoltán Orémuš, Jakub Strejcek, Antonio Mani, Maurice Peemen, Maurits Diephuis, Nathaniel Burley, Lucas Winiarski, John Flanagan, Christopher John Hakala, Hayley Maren Johanesen
  • Publication number: 20260083829
    Abstract: The present application provides for compositions comprising high concentrations of acid ?-glucosidase in combination with an active site-specific chaperone for the acid ?-glucosidase, and methods for treating Pompe disease in a subject in need thereof, that includes a method of administering to the subject such compositions. The present application also provides methods for increasing the in vitro and in vivo stability of an acid ?-glucosidase enzyme formulation.
    Type: Application
    Filed: September 22, 2025
    Publication date: March 26, 2026
    Applicant: Amicus Therapeutics, Inc.
    Inventors: Kenneth Valenzano, John Crowley, Richie Khanna, John Flanagan
  • Patent number: 12567165
    Abstract: Methods include acquiring a series of images or spectra of a volume of a model sample, reconstructing a 3D image of the volume of the model sample using the series of images, constructing a 3D model of the volume of the model sample by forming a segmentation of the reconstructed 3D image and fitting one or more primitive geometrical shapes to the segmentation, acquiring test sample images or spectra, and measuring test sample critical dimensions using the constructed 3D model to guide analysis of test spectra or images. Additional methods and related systems are disclosed, optical critical dimension (OCD) methods and systems.
    Type: Grant
    Filed: February 2, 2022
    Date of Patent: March 3, 2026
    Assignee: FEI Company
    Inventors: John Flanagan, Mary Wu, Erik Franken, Daniel Lichau
  • Patent number: 12419937
    Abstract: The present application provides for compositions comprising high concentrations of acid ?-glucosidase in combination with an active site-specific chaperone for the acid ?-glucosidase, and methods for treating Pompe disease in a subject in need thereof, that includes a method of administering to the subject such compositions. The present application also provides methods for increasing the in vitro and in vivo stability of an acid ?-glucosidase enzyme formulation.
    Type: Grant
    Filed: March 21, 2022
    Date of Patent: September 23, 2025
    Assignee: Amicus Therapeutics, Inc.
    Inventors: Kenneth Valenzano, John Crowley, Richie Khanna, John Flanagan
  • Publication number: 20250259310
    Abstract: Methods and systems for implementing artificial intelligence enabled metrology are disclosed. An example method includes segmenting a first image of structure into one or more classes to form an at least partially segmented image, associating at least one class of the at least partially segmented image with a second image, and performing metrology on the second image based on the association with at least one class of the at least partially segmented image.
    Type: Application
    Filed: April 3, 2025
    Publication date: August 14, 2025
    Inventors: John Flanagan, Brad Larson, Thomas Miller
  • Patent number: 12362137
    Abstract: Systems and methods for automated sample alignment for microscopy are described herein. In one aspect a method can include: rotating the sample along a first axis by each of a plurality of rotation angles; imaging, with a charged particle beam, the sample for each rotation angle; and determining a first rotation angle based on the image for each rotation angle, wherein the first rotation angle aligns the sample to the charged particle beam in relation to the first axis.
    Type: Grant
    Filed: July 6, 2022
    Date of Patent: July 15, 2025
    Assignee: FEI Company
    Inventors: John Flanagan, Michael Strauss
  • Publication number: 20250224397
    Abstract: The present invention relates to an immunoassay for the detection of Borrelia specific IgG, IgM and IgG/IgM antibodies in biological samples suspected of Lyme infection. The immunoassay can be performed via a standard immunoassay format or on an automated platform. In various embodiments, the immunoassay uses one or more Borrelia specific chimeric peptides VlsE-FlaB (designated pFlaB-mV), VlsE-ErpP (designated pErp59-mV), VlsE-P35 (designated pP35-mV) alone or in combination with one or more outer surface protein C (Osp C) types B or I, p58 and DbpA. Other aspects of the invention provide antigen/substrate combinations and compositions comprising combinations of the disclosed peptides and/or proteins for use in the immunoassays described herein.
    Type: Application
    Filed: January 6, 2025
    Publication date: July 10, 2025
    Inventors: MICHELLE DELANOY, JOHN FLANAGAN, AUDREY ARJOMANDI, RAVI KAUL, STEVEN R. BINDER
  • Publication number: 20250209647
    Abstract: Systems or techniques are provided for image metrology. In various embodiments, a system can comprise a memory that stores computer executable components and a processor that executes the computer executable components stored in the memory. The computer executable components can comprise a measurement component that accesses a k-distance data tree comprising positional coordinates of a plurality of shapes within an image; and measures distances between neighboring shapes of the plurality of shapes, wherein the measuring comprises parsing the k-distance data tree for nearest neighbor shapes within the plurality of shapes.
    Type: Application
    Filed: November 6, 2024
    Publication date: June 26, 2025
    Inventors: Spencer Forell, John Flanagan
  • Patent number: 12299185
    Abstract: A storage port receives a login request. The storage port configures an audit mode indicator as enabled in a login response to a host port to enter a security enabled mode to indicate to the host port that Input/Output (I/O) operations are to be transmitted from the host port to the storage port even if authentication or security association negotiation with the storage port cannot be completed successfully.
    Type: Grant
    Filed: March 7, 2022
    Date of Patent: May 13, 2025
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Roger G. Hathorn, Patricia G. Driever, John Flanagan, Christopher J. Colonna, Evan Rivera
  • Patent number: 12293525
    Abstract: Methods and systems for implementing artificial intelligence enabled metrology are disclosed. An example method includes segmenting a first image of structure into one or more classes to form an at least partially segmented image, associating at least one class of the at least partially segmented image with a second image, and performing metrology on the second image based on the association with at least one class of the at least partially segmented image.
    Type: Grant
    Filed: October 13, 2022
    Date of Patent: May 6, 2025
    Assignee: FEI Company
    Inventors: John Flanagan, Brad Larson, Thomas Miller
  • Publication number: 20250120968
    Abstract: The present application relates to treating and/or preventing breast cancer, including locally advanced or metastatic, ER+, HER2? breast cancer, in a subject in need of treatment, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt, enantiomer, stereoisomer, solvate, polymorph, isotopic derivative, or prodrug thereof, wherein R1, R2, R3, R4, m, and n are defined herein.
    Type: Application
    Filed: December 19, 2024
    Publication date: April 17, 2025
    Inventors: Xin CHEN, Andrew P. CREW, John FLANAGAN, Sheryl Maxine GOUGH, Royal J. HASKELL, III, Marcia Dougan MOORE, Yimin QIAN, Ian Charles Anthony TAYLOR, Jing WANG
  • Publication number: 20250082621
    Abstract: The present invention provides methods to determine whether a patient with a lysosomal storage disorder will benefit from treatment with a specific pharmacological chaperone. The present invention exemplifies an in vitro method for determining ?-galactosidase A responsiveness to a pharmacological chaperone such as 1-deoxygalactonojirimycin in a cell line expressing a mutant from of ?-galactosidase A. The invention also provides a method for diagnosing Fabry disease in patients suspected of having Fabry disease.
    Type: Application
    Filed: October 26, 2020
    Publication date: March 13, 2025
    Applicant: AMICUS THERAPEUTICS, INC.
    Inventors: Elfrida Benjamin, Hung V. Do, Xiaoyang Wu, John Flanagan, Brandon Alan Wustman
  • Patent number: 12208095
    Abstract: The present application relates to treating and/or preventing breast cancer, including locally advanced or metastatic, ER+, HER2? breast cancer, in a subject in need of treatment, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt, enantiomer, stereoisomer, solvate, polymorph, isotopic derivative, or prodrug thereof, wherein R1, R2, R3, R4, m, and n are defined herein.
    Type: Grant
    Filed: August 24, 2020
    Date of Patent: January 28, 2025
    Assignee: Arvinas Operations, Inc.
    Inventors: Andrew P. Crew, John Flanagan, Sheryl Maxine Gough, Royal J. Haskell, III, Marcia Dougan Moore, Yimin Qian, Ian Charles Anthony Taylor, Jing Wang
  • Patent number: 12188931
    Abstract: The present invention relates to an immunoassay for the detection of Borrelia specific IgG, IgM and IgG/IgM antibodies in biological samples suspected of Lyme infection. The immunoassay can be performed via a standard immunoassay format or on an automated platform. In various embodiments, the immunoassay uses one or more Borrelia specific chimeric peptides VlsE-FlaB (designated pFlaB-mV), VlsE-ErpP (designated pErp59-mV), VlsE-P35 (designated pP35-mV) alone or in combination with one or more outer surface protein C (Osp C) types B or I, p58 and DbpA. Other aspects of the invention provide antigen/substrate combinations and compositions comprising combinations of the disclosed peptides and/or proteins for use in the immunoassays described herein.
    Type: Grant
    Filed: December 27, 2021
    Date of Patent: January 7, 2025
    Assignee: BIO-RAD LABORATORIES, INC.
    Inventors: Michelle Delanoy, John Flanagan, Audrey Arjomandi, Ravi Kaul, Steven R. Binder
  • Publication number: 20240428400
    Abstract: Systems, components, methods, and algorithms for generating template information are described. a computer-implemented method includes receiving microscope image data, detecting a feature in the microscope image data, receiving feature template data describing a grouping of features including the feature, detecting the grouping in the microscope image data based at least in part on the feature template data, generating template information describing the grouping, and outputting the template information.
    Type: Application
    Filed: June 26, 2023
    Publication date: December 26, 2024
    Inventors: John Flanagan, Hayley Johanesen, Lucas Paul Winiarski, Christopher Hakala
  • Publication number: 20240354924
    Abstract: Disclosed herein are scientific instrument support systems, as well as related methods, computing devices, and computer-readable media. For example, in some embodiments, a scientific instrument support apparatus may include: first logic to receive, from a charged particle microscope, a microscopy image of a sample; second logic to generate a first processed image by processing the microscopy image through a general machine-learning model trained using a plurality of previously processed microscopy images; third logic to retrain the general machine-learning model with a related microscopy image, wherein the related microscopy image includes a label of an object related to the sample and the related microscopy image is not included in the plurality of previously processed microscopy images; and fourth logic to generate a second processed image, different from the first processed image, by processing the microscopy image through the retrained general machine-learning model.
    Type: Application
    Filed: April 19, 2023
    Publication date: October 24, 2024
    Inventors: John Flanagan, Andrei Novikov
  • Patent number: 11953438
    Abstract: An improved device and system for facilitating polymerase chain reaction including a light source, detector, waveguide, and filters that occupy minimal space and facilitate detection of stationary samples, reduced sample read time, and simultaneous reading of multiple light wavelengths.
    Type: Grant
    Filed: June 17, 2022
    Date of Patent: April 9, 2024
    Assignee: STRECK LLC
    Inventors: Matthew R. Kreifels, Scott E. Whitney, Gregg Wilder, John Flanagan, James Dowling, Philip Hills, Michael Tilleman, Jeremie Jackson
  • Publication number: 20240094223
    Abstract: The invention provides a method of diagnosing Non-Alcoholic Steatohepatitis (NASH) and/or the hepatic fibrosis status of a subject, especially a subject afflicted with Non-alcoholic fatty liver disease (NAFLD) or NASH, based on the level of only three or more particular biomarkers. The invention further provides a kit suitable for performing said method and the use of said method and methods of treating patients diagnosed in accordance with the disclosed methods.
    Type: Application
    Filed: November 6, 2023
    Publication date: March 21, 2024
    Inventors: ISABELLE BATXELLI-MOLINA, FLORIAN SALIPANTE, ROGER P. WALKER, JOHN FLANAGAN, JEANNETTE FAREH-MICHIEL